FDA Drug Application (090815) for IRBESARTAN; HYDROCHLOROTHIAZIDE by ZYDUS PHARMS USA INC

Back to FDA Applications sponsored by ZYDUS PHARMS USA INC

Application Number090815
Product Number001
FormTABLET; ORAL
Dosage150MG; 12.5MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameIRBESARTAN; HYDROCHLOROTHIAZIDE
Active IngredientIRBESARTAN; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient IRBESARTAN7


Back to FDA Applications sponsored by ZYDUS PHARMS USA INC